Diclofenac for Prevention of Post-ERC Pancreatitis

NCT03595150 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Common Bile Duct Diseases

Interventions

DRUG: Diclofenac

Sponsor

Karolinska Institutet

Collaborators

[object Object]